Brodalumab in Palmoplantar Psoriasis
NCT04622033
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Palmoplantar Psoriasis
Interventions
BIOLOGICAL:
Brodalumab
Sponsor
First OC Dermatology